Opaleye Management’s Prothena Corp PRTA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2017
Q3
Sell
-85,000
Closed -$4.6M 37
2017
Q2
$4.6M Sell
85,000
-2,100
-2% -$112K 1.92% 19
2017
Q1
$4.86M Buy
87,100
+4,600
+6% +$242K 2.42% 17
2016
Q4
$4.06M Buy
82,500
+32,500
+65% +$1.79M 2.39% 15
2016
Q3
$3M Buy
+50,000
New +$2.68M 1.57% 23
2016
Q2
Sell
-14,000
Closed -$576K 54
2016
Q1
$576K Buy
+14,000
New +$548K 0.36% 47
2014
Q4
Sell
-157,000
Closed -$3.48M 38
2014
Q3
$3.48M Buy
157,000
+143,896
+1,098% +$3.05M 2.71% 15
2014
Q2
$295K Buy
+13,104
New +$328K 0.25% 27

Other funds holding PRTA

Opaleye Management's PRTA Position: Q3 2017 in Review

Opaleye Management sold out of Prothena Corp (PRTA) in Q3 2017, closing a stake of 85,000 shares — an estimated $4.6M sold.

Opaleye Management first reported a position in PRTA in Q2 2014 and held it in 7 quarters. The position peaked at $4.86M in Q1 2017. 153 funds tracked by Wall St. Rank hold PRTA as of Q3 2017.

  • Opaleye Management reported no remaining Prothena Corp position as of Q3 2017 after selling out during the quarter.
  • Opaleye Management sold 85,000 Prothena Corp shares in Q3 2017, an estimated $4.6M.
  • Opaleye Management first reported a position in Prothena Corp in Q2 2014 and held it in 7 quarters.
  • Opaleye Management's Prothena Corp position peaked at $4.86M in Q1 2017.
  • 153 funds tracked by Wall St. Rank held Prothena Corp as of Q3 2017.

Based on Opaleye Management's 13F filing for Q3 2017, filed 14 Nov 2017.